Cargando…
A cross-section observational study on the seroprevalence of antibodies to COVID-19 in patients receiving opiate agonist treatment
INTRODUCTION: The HSE National Drug Treatment Centre is an inner city drug treatment centre in Dublin which provides opiate agonist treatment (OAT) to approximately 565 patients, many of whom have complex care needs. OBJECTIVE: This study was conducted to determine seropositivity to the COVID-19 vir...
Autores principales: | Fenton, Fiona, Stokes, Siobhan, Eagleton, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267507/ https://www.ncbi.nlm.nih.gov/pubmed/34241774 http://dx.doi.org/10.1007/s11845-021-02660-w |
Ejemplares similares
-
Correction to: A cross‑section observational study on the seroprevalence of antibodies to COVID‑19 in patients receiving opiate agonist treatment
por: Fenton, Fiona, et al.
Publicado: (2021) -
Does opioid substitution treatment have a protective effect on the clinical manifestations of COVID-19? Comment on Br J Anaesth 2020; 125: e382–3
por: Eagleton, Marie, et al.
Publicado: (2021) -
Therapeutic potential of long-acting opioids and opioid antagonists for SARS-CoV-2 infection
por: Eagleton, Marie, et al.
Publicado: (2021) -
Expansion of opiate agonist treatment: an historical perspective
por: Newman, Robert G
Publicado: (2006) -
Opiate agonist treatment to improve health of individuals with opioid use disorder in Lebanon
por: Ghaddar, Ali, et al.
Publicado: (2017)